Tina Pasciuto

Medicine and Dentistry

1. Patient 100%
2. Neoplasm 82%
3. Cervical Cancer 57%
4. Ovarian Cancer 39%
5. Chemoradiotherapy 36%
6. Ovarian Tumor 32%
7. Observational Study 28%
8. Diseases 27%
9. Woman 26%
10. PET-CT 25%
11. Analysis 24%
12. Lymph Node 24%
13. Cytoreductive Surgery 23%
14. Endometrial Cancer 23%
15. Radical Surgery 23%
16. Cancer 23%
17. Gynecologic Disease 23%
18. Prematurity 22%
19. Overall Survival 22%
20. Surgery 22%
21. Examination 21%
22. Uterine Cancer 21%
23. Arm 20%
24. Metastatic Carcinoma 20%
25. Krukenberg Tumor 20%
26. Recurrent Disease 20%
27. Vulvar Cancer 19%
28. Ovary Metastasis 19%
29. Magnetic Resonance Imaging 18%
30. Fluorodeoxyglucose F 18 18%
31. Neoadjuvant Therapy 17%
32. Assessment 17%
33. Pelvis 17%
34. Neoadjuvant Chemotherapy 17%
35. Therapeutic Procedure 16%
36. Neonatal Infant 16%
37. Diagnostic Performance 16%
38. Disease Free Survival 16%
39. Uterus Sarcoma 15%
40. Polyethylene Terephthalate 15%
41. Radiomics 15%
42. Exposome 15%
43. Minimal Residual Disease 15%
44. Sentinel Node 15%
45. Malignant Neoplasm 14%
46. Sentinel Lymph Node 14%
47. Inpatient 14%
48. Primary Tumor 13%
49. Environmental Exposure 12%
50. Gynecological Oncology 12%